10,000 Procedure Milestone for OMNIBotics
OMNIlife science announced completion of >10,000 total knee replacements worldwide using OMNIBotics™ robotic-assisted total knee replacement technology....
Nov 11, 2016,
10,000 Procedure Milestone for OMNIBotics
Medtronic Launches Orthopaedic Solutions Business
Medtronic Orthopedic Solutions has launched to support total joint replacement episodes of care, including introduction of a total knee arthroplasty system....
Nov 10, 2016,
Fidia’s HYMOVIS Receives Product-Specific J-Code
CMS assigned a unique HCPCS reimbursement code to Fidia Pharma’s HYMOVIS® highly viscoelastic, non-crosslinked hydrogel to treat knee osteoarthritis pain. ...
Nov 10, 2016,
Limited Launch of KATOR Suture Anchor
KATOR commenced limited launch of its KATOR Suture Anchor system and has completed the first surgical case....
Nov 10, 2016,
Smith & Nephew’s eCAP Adopted by Provider PPI
Provider PPI, a U.S. health and wellness organization, has adopted Smith & Nephew’s Episode of Care Assurance Program (eCAP), a solution designed...
Nov 08, 2016,
joimax FDA Clearance for Vaporflex and Legato Electrosurgical Probes
joimax received FDA 510(k) clearance to market Vaporflex® and Legato® electrosurgical probes with radiowave technology for open and endoscopic spine surgery....
Nov 08, 2016,
Seikagaku Enters U.S. Distribution Agreement with Zimmer Biomet for VISCO-3
Seikagaku entered into an exclusive agreement with Zimmer Biomet for U.S. distribution of VISCO-3™, a 3-injection hyaluronic acid-based viscosupplement for...
Nov 08, 2016,
SeaSpine Receives FDA 510(k) Clearance for Mariner Posterior Fixation
SeaSpine received FDA 510(k) clearance to market the Mariner™ Posterior Fixation pedicle screw system....
Nov 08, 2016,
KATOR Receives FDA Clearance for Knotless Suture Anchor
KATOR received a second FDA 510(k) clearance for the KATOR suture anchor, expanding the system for use with 2mm high-strength suture tape....
Nov 08, 2016,
Bone Therapeutics Restates Priorities
Bone Therapeutics will not pursue U.S. clinical development of PREOB® autologous cell therapy. In the U.S., priority will be given...
Nov 08, 2016,
Loading new posts...
No more posts
